Arbutus Biopharma ABUS
NASDAQ ABUS
$3.88 +0.15 (+4.17%)
As of: Nov 10, 2026 · 1:02 PM EST

Arbutus Biopharma (ABUS) Net Long-Term Debt Issued (Repaid) (2018)

Updated

Arbutus Biopharma (ABUS) reported Non-Current Debt of $12 million for Q4 2017, unchanged from $12 million a year earlier and unchanged from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Net Long-Term Debt Issued (Repaid) (2018) Analysis & Trends

Dating back to Q4 2016, Arbutus Biopharma's Non-Current Debt record includes 5 quarters.

  • By year, Non-Current Debt came in at $12 million in FY2016.
  • Per Business Quant data, the three quarters before Q4 2017 came in at $12 million (Q3 2017), $12 million (Q2 2017) and $12 million (Q1 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Arbutus Biopharma 755.33 Mn 382.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -12.00 Mn
API Access

Arbutus Biopharma Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ABUS&period=max&api_key=YOUR_API_KEY